FDA Approves Olutasidenib for Relapsed or Refractory AML with a Susceptible IDH1 Mutation

Advancing Critical Priorities at the State Level: Louisiana, Iowa, and Washington Awarded for Their Efforts at 2026 ASCO Annual Meeting

At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.